Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dynein light chain binding	DYNC1I1 DYNC1I2	2.81e-04	12	42	2	GO:0045503
GeneOntologyMolecularFunction	protein antigen binding	HLA-DQB2 LPA	5.09e-04	16	42	2	GO:1990405
GeneOntologyMolecularFunction	dynein heavy chain binding	DYNC1I1 DYNC1I2	5.76e-04	17	42	2	GO:0045504
GeneOntologyMolecularFunction	toxic substance binding	AHR HLA-DQB2	6.47e-04	18	42	2	GO:0015643
GeneOntologyBiologicalProcess	peripheral B cell selection	HLA-DQB2 BTK	2.42e-05	4	42	2	GO:0002343
GeneOntologyBiologicalProcess	B cell affinity maturation	HLA-DQB2 BTK	2.42e-05	4	42	2	GO:0002344
GeneOntologyBiologicalProcess	B cell selection	HLA-DQB2 BTK	6.04e-05	6	42	2	GO:0002339
GeneOntologyBiologicalProcess	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	GATA3 AHR HLA-DQB2 BTK HLA-F	1.11e-04	235	42	5	GO:0002822
GeneOntologyBiologicalProcess	regulation of adaptive immune response	GATA3 AHR HLA-DQB2 BTK HLA-F	1.54e-04	252	42	5	GO:0002819
Domain	DYNC1I1/DYNC1I2	DYNC1I1 DYNC1I2	4.70e-06	2	41	2	IPR025956
Domain	Dynein_IC2	DYNC1I1 DYNC1I2	4.70e-06	2	41	2	PF11540
Domain	-	GHR MST1R VSTM4 AREL1 HMCN1 HLA-DQB2 HLA-F	5.40e-04	663	41	7	2.60.40.10
Domain	-	CACHD1 MDN1 HMCN1	5.71e-04	74	41	3	3.40.50.410
Domain	VWFA	CACHD1 MDN1 HMCN1	7.71e-04	82	41	3	PS50234
Domain	Ig-like_fold	GHR MST1R VSTM4 AREL1 HMCN1 HLA-DQB2 HLA-F	7.84e-04	706	41	7	IPR013783
Domain	VWA	CACHD1 MDN1 HMCN1	8.27e-04	84	41	3	SM00327
Domain	VWF_A	CACHD1 MDN1 HMCN1	1.33e-03	99	41	3	IPR002035
Domain	MHC_I/II-like_Ag-recog	HLA-DQB2 HLA-F	3.14e-03	38	41	2	IPR011162
Domain	SH3_1	CASS4 BTK NGEF	5.55e-03	164	41	3	PF00018
Domain	-	MST1R DYNC1I1 DYNC1I2 COPB2	5.98e-03	333	41	4	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	MST1R DYNC1I1 DYNC1I2 COPB2	6.10e-03	335	41	4	IPR015943
Domain	C1-set	HLA-DQB2 HLA-F	6.26e-03	54	41	2	PF07654
Domain	IGc1	HLA-DQB2 HLA-F	6.72e-03	56	41	2	SM00407
Domain	Ig_C1-set	HLA-DQB2 HLA-F	7.19e-03	58	41	2	IPR003597
Domain	Ig/MHC_CS	HLA-DQB2 HLA-F	7.19e-03	58	41	2	IPR003006
Domain	IG_MHC	HLA-DQB2 HLA-F	7.68e-03	60	41	2	PS00290
Domain	Zinc_finger_PHD-type_CS	MLLT10 NFX1	8.96e-03	65	41	2	IPR019786
Domain	SH3	CASS4 BTK NGEF	1.18e-02	216	41	3	SM00326
Domain	SH3	CASS4 BTK NGEF	1.18e-02	216	41	3	PS50002
Pubmed	c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3.	GATA3 HLA-DQB2 MYB	6.54e-09	4	42	3	17641686
Pubmed	Keratinocyte-intrinsic MHCII expression controls microbiota-induced Th1 cell responses.	AHR HLA-DQB2 HLA-F	9.13e-08	8	42	3	31672911
Pubmed	High-resolution comparative mapping of mouse chromosome 17.	HLA-DQB2 LPA HLA-F	9.07e-07	16	42	3	8406442
Pubmed	Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human.	DYNC1I1 DYNC1I2	1.42e-06	2	42	2	10049579
Pubmed	GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.	GATA3 MYB	1.42e-06	2	42	2	28323779
Pubmed	Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts.	DYNC1I1 DYNC1I2	1.42e-06	2	42	2	20657784
Pubmed	Non-MHC-linked genes in autoimmune diseases.	HEPH BTK	4.27e-06	3	42	2	8297521
Pubmed	Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.	GATA3 AHR	4.27e-06	3	42	2	20130088
Pubmed	The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.	GATA3 MYB	4.27e-06	3	42	2	20383148
Pubmed	Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.	GATA3 MYB	8.53e-06	4	42	2	23444353
Pubmed	c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.	GATA3 MYB	8.53e-06	4	42	2	22039304
Pubmed	c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.	GATA3 MYB	8.53e-06	4	42	2	20484083
Pubmed	The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin.	MDN1 PES1	1.42e-05	5	42	2	26601951
Pubmed	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	GATA3 MYB	1.42e-05	5	42	2	24149102
Pubmed	Interaction of SQSTM1 with the motor protein dynein--SQSTM1 is required for normal dynein function and trafficking.	DYNC1I1 DYNC1I2	1.42e-05	5	42	2	25015291
Pubmed	Aryl hydrocarbon receptor signals in epithelial cells govern the recruitment and location of Helios+ Tregs in the gut.	AHR HLA-DQB2	1.42e-05	5	42	2	35545035
Pubmed	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.	DYNC1I1 DYNC1I2	1.42e-05	5	42	2	30250299
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	POM121C GRM7 EMSY NGEF	1.50e-05	123	42	4	26912792
Pubmed	Animal models of lysosomal disease: an overview.	DYNC1I1 DYNC1I2	2.13e-05	6	42	2	9728334
Pubmed	CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy.	HLA-DQB2 HLA-F	2.13e-05	6	42	2	32012249
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	GHR DYNC1I1 DYNC1I2	2.56e-05	47	42	3	8812413
Pubmed	Temporal profiles of the subcellular localization of Bim, a BH3-only protein, during middle cerebral artery occlusion in mice.	DYNC1I1 DYNC1I2	2.98e-05	7	42	2	12142566
Pubmed	A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins.	DYNC1I1 DYNC1I2	2.98e-05	7	42	2	11751894
Pubmed	A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system.	DYNC1I1 DYNC1I2	2.98e-05	7	42	2	11163259
Pubmed	Histocompatibility gene mutation rates in the mouse: a 25-year review.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	9382920
Pubmed	Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	8500908
Pubmed	Polymorphism of the mouse H-2 loci.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	7030925
Pubmed	Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	15153510
Pubmed	H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	6407984
Pubmed	Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	6415206
Pubmed	HIV-1 uncoating is facilitated by dynein and kinesin 1.	DYNC1I1 DYNC1I2	3.97e-05	8	42	2	25231297
Pubmed	HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.	DYNC1I1 DYNC1I2	3.97e-05	8	42	2	25818806
Pubmed	Mapping of the genes encoding mouse thromboxane A2 receptor and prostaglandin E receptor subtypes EP2 and EP3.	GHR MYB	3.97e-05	8	42	2	7910583
Pubmed	Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1.	HLA-DQB2 BTK	3.97e-05	8	42	2	12634786
Pubmed	Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.	HLA-DQB2 HLA-F	3.97e-05	8	42	2	29472249
Pubmed	In vivo requirement for Atg5 in antigen presentation by dendritic cells.	HLA-DQB2 HLA-F	5.10e-05	9	42	2	20171125
Pubmed	Transport of the outer dynein arm complex to cilia requires a cytoplasmic protein Lrrc6.	DYNC1I1 DYNC1I2	5.10e-05	9	42	2	27353389
Pubmed	The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.	GATA3 AHR	5.10e-05	9	42	2	23063333
Pubmed	Distinct temporal patterns of T cell receptor signaling during positive versus negative selection in situ.	HLA-DQB2 HLA-F	5.10e-05	9	42	2	24129702
Pubmed	Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus.	HLA-DQB2 HLA-F	5.10e-05	9	42	2	17446933
Pubmed	Regulation of GATA-3 expression during CD4 lineage differentiation.	GATA3 MYB	6.37e-05	10	42	2	21357543
Pubmed	Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	37712758
Pubmed	Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	30383447
Pubmed	Gene mapping within the T/t complex of the mouse. IV: The inverted MHC is intermingled with several t-lethal genes.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	6096010
Pubmed	Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	38426910
Pubmed	Gene organization and recombinational hotspots in the murine major histocompatibility complex.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	3754180
Pubmed	Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	18684933
Pubmed	NLGN4X TCR transgenic T cells to treat gliomas.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	37715782
Pubmed	A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	12242444
Pubmed	The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	12119351
Pubmed	CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	19808251
Pubmed	HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	37877672
Pubmed	Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	23869841
Pubmed	Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	37219526
Pubmed	Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.	HLA-DQB2 HLA-F	6.37e-05	10	42	2	37966111
Pubmed	Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	20466823
Pubmed	Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	25857745
Pubmed	Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	16860760
Pubmed	Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	29988124
Pubmed	Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	16365422
Pubmed	An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals.	HLA-DQB2 HLA-F	7.78e-05	11	42	2	10377186
Pubmed	Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin.	HLA-DQB2 HLA-F	9.32e-05	12	42	2	12150895
Pubmed	Patterned variation in murine MHC promoters.	HLA-DQB2 HLA-F	9.32e-05	12	42	2	12134058
Pubmed	Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B.	HLA-DQB2 BTK	9.32e-05	12	42	2	10611342
Pubmed	Extensive polymorphism surrounding the murine Ia A beta chain gene.	HLA-DQB2 HLA-F	1.10e-04	13	42	2	6311906
Pubmed	cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.	HLA-DQB2 HLA-F	1.10e-04	13	42	2	32788723
Pubmed	Cytoplasmic dynein nomenclature.	DYNC1I1 DYNC1I2	1.10e-04	13	42	2	16260502
Pubmed	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.	AHR HLA-DQB2	1.10e-04	13	42	2	25908663
Pubmed	The I region of the C57BL/10 mouse: characterization and physical linkage to H-2K of an SB beta-like class II pseudogene, psi A beta 3.	HLA-DQB2 HLA-F	1.28e-04	14	42	2	3860873
Pubmed	Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.	DYNC1I1 DYNC1I2	1.28e-04	14	42	2	21471385
Pubmed	No dosage effect of recombinational hotspots in the mouse major histocompatibility complex.	HLA-DQB2 HLA-F	1.28e-04	14	42	2	7910587
Pubmed	BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures.	DYNC1I1 DYNC1I2	1.28e-04	14	42	2	22956769
Pubmed	Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.	HLA-DQB2 HLA-F	1.48e-04	15	42	2	38413714
Pubmed	CD8αα⁺ innate-type lymphocytes in the intestinal epithelium mediate mucosal immunity.	AHR HLA-F	1.48e-04	15	42	2	25220211
Pubmed	Localization of a mouse heat shock Hsp70 gene within the H-2 complex.	HLA-DQB2 HLA-F	1.91e-04	17	42	2	1978715
Pubmed	Tracts of high or low sequence divergence in the mouse major histocompatibility complex.	HLA-DQB2 HLA-F	2.15e-04	18	42	2	6098460
Pubmed	The aryl hydrocarbon receptor promotes differentiation during mouse preimplantational embryo development.	GATA3 AHR	2.40e-04	19	42	2	34478649
Pubmed	Nef performance in macrophages: the master orchestrator of viral persistence and spread.	HLA-DQB2 HLA-F	2.67e-04	20	42	2	22103834
Pubmed	HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells.	HLA-DQB2 HLA-F	2.67e-04	20	42	2	12427289
Pubmed	Human transcription factor protein interaction networks.	GATA3 MLLT10 POM121C ATXN2 EMSY PES1 MYB COPB2	2.70e-04	1429	42	8	35140242
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	PLEKHA5 POM121C ATXN2 NFX1	2.85e-04	263	42	4	34702444
Pubmed	Jak2 is essential for signaling through a variety of cytokine receptors.	GATA3 MYB	2.95e-04	21	42	2	9590173
Pubmed	HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41.	HLA-DQB2 HLA-F	2.95e-04	21	42	2	8084338
Pubmed	Colinearity of novel genes in the class II regions of the MHC in mouse and human.	HLA-DQB2 HLA-F	2.95e-04	21	42	2	1855816
Pubmed	Neuronal-Specific TUBB3 Is Not Required for Normal Neuronal Function but Is Essential for Timely Axon Regeneration.	DYNC1I1 DYNC1I2	2.95e-04	21	42	2	30110642
Pubmed	Recombination in the class III region of the mouse major histocompatibility complex.	HLA-DQB2 HLA-F	3.24e-04	22	42	2	7916002
Pubmed	Proximity Labeling Reveals Spatial Regulation of the Anaphase-Promoting Complex/Cyclosome by a Microtubule Adaptor.	PLEKHA5 COPB2	3.24e-04	22	42	2	35952650
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MST1R LAMB2 MDN1 MLLT10 POM121C MARK4 NFX1	3.27e-04	1105	42	7	35748872
Pubmed	Role of HIV-1 Nef protein for virus replication in vitro.	HLA-DQB2 HLA-F	3.54e-04	23	42	2	19770068
Pubmed	Distinct dynein complexes defined by DYNLRB1 and DYNLRB2 regulate mitotic and male meiotic spindle bipolarity.	DYNC1I1 DYNC1I2	3.54e-04	23	42	2	36973253
Pubmed	Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human.	MST1R HLA-F	3.86e-04	24	42	2	2902634
Pubmed	Editorial. Nef: a notorious enigmatic factor in HIV biology.	HLA-DQB2 HLA-F	3.86e-04	24	42	2	22175768
Pubmed	HIV accessory proteins and surviving the host cell.	HLA-DQB2 HLA-F	4.20e-04	25	42	2	16091223
Pubmed	[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway].	HLA-DQB2 HLA-F	4.90e-04	27	42	2	12836198
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	PLEKHA5 HEPH BTK	4.92e-04	127	42	3	30442766
Pubmed	One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef.	HLA-DQB2 HLA-F	5.28e-04	28	42	2	22103833
Pubmed	HIV/SIV escape from immune surveillance: focus on Nef.	HLA-DQB2 HLA-F	5.66e-04	29	42	2	15078178
Pubmed	STK11 is required for the normal program of ciliated cell differentiation in airways.	MYB MARK4	6.47e-04	31	42	2	31636950
Pubmed	Immunoregulatory effects of HIV-1 Nef protein.	HLA-DQB2 HLA-F	6.90e-04	32	42	2	19449444
Pubmed	The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.	MYB HLA-F	7.79e-04	34	42	2	1686571
GeneFamily	Dyneins, cytoplasmic	DYNC1I1 DYNC1I2	2.19e-04	13	31	2	538
GeneFamily	C1-set domain containing	HLA-DQB2 HLA-F	2.35e-03	42	31	2	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DQB2 HLA-F	2.57e-03	44	31	2	588
GeneFamily	WD repeat domain containing	DYNC1I1 DYNC1I2 COPB2	1.00e-02	262	31	3	362
GeneFamily	PHD finger proteins	MLLT10 NFX1	1.04e-02	90	31	2	88
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP	GATA3 AHR PLEKHA5 MDN1 ATXN2	1.33e-05	191	42	5	M8251
ToppCell	11.5-Airway-RBC-RBC\|Airway / Age, Tissue, Lineage and Cell class	SLC22A16 HSF5 BTK MYB	1.75e-05	165	42	4	8618b2c5659aa70c7c9d6e51a227ac612b4ad17b
ToppCell	11.5-Airway-RBC\|Airway / Age, Tissue, Lineage and Cell class	SLC22A16 HSF5 BTK MYB	1.75e-05	165	42	4	46042340a373adaf1c439b2301e02fbae3e31a4f
ToppCell	wk_08-11-Hematologic_Lymphocytic-B-Late_pro-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SLC22A16 BTK MYB HLA-F	1.97e-05	170	42	4	ad69ebfda452e19eedc453e1d07dacb844d64e47
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GATA3 KLK8 AHR DYNC1I1	2.01e-05	171	42	4	3112d15f2a28cf4a71992db4971d960716dc1264
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GHR GRM7 BTK MYB	2.21e-05	175	42	4	9a96794df049d8228fea57c1584c160191d36b56
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GATA3 GHR KLK8 DYNC1I1	2.36e-05	178	42	4	0139b42494c1186390b12106dea7957e2b6717c2
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB HLA-F	2.41e-05	179	42	4	223f0895da89c7606f637aef113912dd06f39c5a
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB HLA-F	2.46e-05	180	42	4	cb6b11883f42c8beff07f899036c803d786ac6a3
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GHR CASS4 VSTM4 HMCN1	2.52e-05	181	42	4	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GHR VSTM4 HMCN1 DYNC1I1	2.98e-05	189	42	4	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CASS4 VSTM4 HMCN1 HEPH	3.04e-05	190	42	4	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PLEKHA5 CACHD1 SLC22A16 GRM7	3.23e-05	193	42	4	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MST1R GRM7 DYNC1I1 NGEF	3.72e-05	200	42	4	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MST1R GRM7 DYNC1I1 NGEF	3.72e-05	200	42	4	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MST1R GRM7 DYNC1I1 NGEF	3.72e-05	200	42	4	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-\|Striatum / BrainAtlas - Mouse McCarroll V32	CASS4 TMEM221 BTK	4.68e-05	74	42	3	e89506bd854a43b80f839ace36f7a3eaa8437215
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)\|Striatum / BrainAtlas - Mouse McCarroll V32	CASS4 TMEM221 BTK	4.68e-05	74	42	3	0dbce0b36eaf0c7a8b623478c85d1cac82c6693a
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)\|Striatum / BrainAtlas - Mouse McCarroll V32	CASS4 TMEM221 BTK	4.68e-05	74	42	3	093575ea862f3724d236817f04d98cc06b8addf0
ToppCell	Striatum-Hematopoietic-MICROGLIA\|Striatum / BrainAtlas - Mouse McCarroll V32	CASS4 TMEM221 BTK	4.68e-05	74	42	3	89effada90fbfef1844a905d3f82e9d16666eea5
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--\|Striatum / BrainAtlas - Mouse McCarroll V32	CASS4 TMEM221 BTK	4.68e-05	74	42	3	b14a950b90791a4cc5ffd29eb75a524abdd382da
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KLK8 CASS4 BTK	2.33e-04	127	42	3	0750743574c2fca8df07e11d73e8b94579209609
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LAMB2 SLC22A16 HLA-DQB2	2.61e-04	132	42	3	a1fda8c5287168c4f159203ed27cadfb4ce1b131
ToppCell	Control-Hematopoietic_Mast-Mast_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GATA3 BTK OTOG	3.23e-04	142	42	3	a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd
ToppCell	LPS-IL1RA-Hematopoietic_Mast-Mast_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GATA3 MYB OTOG	3.23e-04	142	42	3	2a9a070e7c53ac593d46c6c5f6983f07d4413501
ToppCell	Control-Hematopoietic_Mast-Mast_cells-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GATA3 BTK OTOG	3.23e-04	142	42	3	70f8c1be134835e0d21e6d426b7122f0f5d3d3e5
ToppCell	LPS-IL1RA-Hematopoietic_Mast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GATA3 MYB OTOG	3.23e-04	142	42	3	f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992
ToppCell	Control-Hematopoietic_Mast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GATA3 BTK OTOG	3.23e-04	142	42	3	db9b7acbab730ae391a362f1ca8177507e52250d
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BTK MYB OTOG	3.36e-04	144	42	3	013223bb2f31eb5bebdbd0908b797d28b96c6f7b
ToppCell	Fetal_29-31_weeks-Immune-mast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC22A16 BTK MYB	3.43e-04	145	42	3	dc89d817a9bef24a07e992efdab4136f12ceb399
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC1\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 HLA-DQB2 HLA-F	3.79e-04	150	42	3	3dc23a37dbeb7f9df93683702a7838f7cc3ec9cc
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GATA3 MDN1 TMEM221	4.09e-04	154	42	3	ec920cae12ea1d14b6c973f6e903f895f80e3c50
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|356C / Donor, Lineage, Cell class and subclass (all cells)	GATA3 AREL1 TCAP	4.25e-04	156	42	3	7ccd20e3bbce6a070df45034b0bdc255f267efb1
ToppCell	severe-CD4+_T_naive\|World / disease stage, cell group and cell class	CASS4 VSTM4 MYB	4.33e-04	157	42	3	ccf9abe0b59e9ea728cec4bba1872ffe14c7385c
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HMCN1 HEPH DYNC1I1	4.49e-04	159	42	3	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	343B-Myeloid-Mast_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	AHR BTK MYB	4.58e-04	160	42	3	a2f09b5955602819c8978f4372130c8ef915cd07
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 TMEM221	4.58e-04	160	42	3	939e25ef8b64242da2d28ef8342c8eb9cd199f17
ToppCell	343B-Myeloid-Mast_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	AHR BTK MYB	4.58e-04	160	42	3	133ecae0a894d9a0d49d58859623359096b6f030
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 MDN1 HSF5	4.75e-04	162	42	3	8a488ecd25ef41468c3c7766eb936dbc2f7665a9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AHR BTK MYB	4.75e-04	162	42	3	30508c4007faa38b76246e3c6d7b3fde4492cc85
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AHR BTK MYB	4.75e-04	162	42	3	33b73c6727b5c5ada2dddf304f56d84397725ca8
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AHR BTK MYB	4.75e-04	162	42	3	44ef0932ee38964ff11edc2aa14698d9db3b2b6b
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	HMCN1 EMSY MYB	4.92e-04	164	42	3	d7053de88ef8e42cac6726a40e72f212659ee034
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA3 BTK MYB	4.92e-04	164	42	3	f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA3 CASS4 HLA-F	5.01e-04	165	42	3	207f9ca8839f54710e2112986def4bc7b0ef1a28
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GATA3 AHR TCAP	5.09e-04	166	42	3	b041010038a570ad929812f35514cb54e4f68f66
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	AHR PES1 MARK4	5.18e-04	167	42	3	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLK8 TMEM221 BTK	5.18e-04	167	42	3	41675d15919104c9e20cd97620fe636f3ff33fa9
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLK8 TMEM221 BTK	5.18e-04	167	42	3	3d5a6a4c7d037b1a6a8ec90034d88ef6d256e843
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	GRM7 HEPH DYNC1I1	5.18e-04	167	42	3	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	severe-CD4+_T_naive\|severe / disease stage, cell group and cell class	CASS4 VSTM4 MYB	5.18e-04	167	42	3	02a8215fca59c357c1cdaa5738849eacf98c0bcc
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF578 HMCN1 HLA-DQB2	5.27e-04	168	42	3	d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB	5.27e-04	168	42	3	c833e3311af2582787d3ff2ad59d802fff865f8f
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AHR HLA-DQB2 HSF5	5.27e-04	168	42	3	d60f7cd8269f373827f49c7785002cb38e4570a9
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BTK MYB HLA-F	5.37e-04	169	42	3	7fd13b6e6041032697d36dd215f6b943d4675cf2
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF578 HMCN1 HLA-DQB2	5.37e-04	169	42	3	d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCell	droplet-Liver-HEPATOCYTES-1m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLK8 AHR PLEKHA5	5.37e-04	169	42	3	d721dbb317a88113b4f76688111908d00f23e899
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AHR HLA-DQB2 HSF5	5.37e-04	169	42	3	ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	5.46e-04	170	42	3	4a241e3c928f29dad179f723b3846991415dadc0
ToppCell	Pericytes-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	GHR HEPH DYNC1I1	5.55e-04	171	42	3	bbc8d9fc83d37c9250345b1e76776610799de9ae
ToppCell	wk_08-11-Hematologic_Lymphocytic-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	BTK MYB HLA-F	5.65e-04	172	42	3	d1ab8f493b70ec995281f9fb0991f1d3aa7b928f
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BTK MYB HLA-F	5.74e-04	173	42	3	67c342295b8a06ce38e081ba74478c568917a396
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHR MST1R MYB	5.84e-04	174	42	3	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHR MST1R MYB	5.84e-04	174	42	3	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHR MST1R MYB	5.84e-04	174	42	3	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMB2 HMCN1 NGEF	5.84e-04	174	42	3	1d157f7a919c8246e83d8060d2a0017c6c781ef3
ToppCell	11.5-Distal-Immune-Hematopoietic,_B_Cells\|Distal / Age, Tissue, Lineage and Cell class	SLC22A16 BTK MYB	5.94e-04	175	42	3	d8ca8fbe5309dab293c335b32f1b138edfdd0b07
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 TMEM221	6.04e-04	176	42	3	e29a13b8152ee84ca82fd1158d96d3f112e3cde3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 HSF5 MYB	6.04e-04	176	42	3	f163cc6d632112aad35a0a9217c6c99fbdd1386e
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 TMEM221	6.04e-04	176	42	3	00510bf8ede0945dfcbd58cc8f34fddf914b6e49
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHR MST1R MYB	6.04e-04	176	42	3	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CASS4 AHR TCAP	6.04e-04	176	42	3	437cfc5e06416bb0fc76d1f9dc106f74e279e880
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MDN1 GRM7	6.14e-04	177	42	3	7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	6.14e-04	177	42	3	52402ff6299210c46fd9dee3cef203c0eda7a98a
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	6.14e-04	177	42	3	6561794ae3b14b5279b249eb5e93b80ef15ed82c
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSTM4 MDN1 GRM7	6.14e-04	177	42	3	e7b1f3092e6b8d0d580f82648035f5ad12be6961
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB	6.14e-04	177	42	3	e0035eb725cd412169af1b424119f6422504af93
ToppCell	facs-BAT-Fat-3m-Lymphocytic-T_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 MYB	6.24e-04	178	42	3	7c101e3957ea9b0d4ebf619d1d02e7e64ae28915
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 HMCN1	6.24e-04	178	42	3	5cc182e6faa7ba5b88378d2c953be29bbbb95a7e
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SLC22A16 BTK MYB	6.24e-04	178	42	3	4e28a8bd5a603518bfe993712ab785308691b5ff
ToppCell	droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	6.24e-04	178	42	3	8aef208b6351143562c87715bb11628880abce94
ToppCell	facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 HMCN1	6.24e-04	178	42	3	f9a16bc3f09c35c7d30e3809da024bc2dcf746ed
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 BTK HLA-F	6.34e-04	179	42	3	8d9bad6507fac0926163807a0bda62a57e7660e3
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LAMB2 HEPH DYNC1I1	6.34e-04	179	42	3	98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GATA3 CACHD1 HMCN1	6.34e-04	179	42	3	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB	6.45e-04	180	42	3	36e8606893cfb055d38f5a76a8f0c5e1742f3df7
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GATA3 AHR GRM7	6.45e-04	180	42	3	a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHA5 CACHD1 NGEF	6.45e-04	180	42	3	1363b3254470f6ff98630d1df83a1bdbacc137e0
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC22A16 BTK MYB	6.45e-04	180	42	3	e76ccbaba18ff27abbd71a41fd3574a5ac5c8fb4
ToppCell	Mesenchymal_cells-Chondrocytes\|Mesenchymal_cells / Lineage and Cell class	KCNA6 DYNC1I1 NGEF	6.45e-04	180	42	3	6e399368430ef3afa9ce1ef0ed90f614ccef9987
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AHR ATP11A CACHD1	6.55e-04	181	42	3	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLC22A16 BTK MYB	6.55e-04	181	42	3	51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373
ToppCell	facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GATA3 KLK8 HMCN1	6.55e-04	181	42	3	72c28baf4fd417ff4a7068603830d55074960144
ToppCell	11.5-Airway-Immune-Hematopoietic,_B_Cells\|Airway / Age, Tissue, Lineage and Cell class	SLC22A16 BTK MYB	6.55e-04	181	42	3	727344d7b2953568b7b3463398c7d56878cf2c2b
ToppCell	facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GATA3 KLK8 HMCN1	6.55e-04	181	42	3	2ac4d3e8987d5a009d7908d8787e18165826202a
ToppCell	facs-Lung-3m-Endothelial-venous_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GATA3 KLK8 HMCN1	6.55e-04	181	42	3	2628c7ac345eaaeecf8e34617e81948925962cb9
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	6.66e-04	182	42	3	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GATA3 AHR GRM7	6.66e-04	182	42	3	6bd48c5d60a259719f65cacee4b8135247e78fa9
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 KLK8 PLEKHA5	6.66e-04	182	42	3	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GATA3 CACHD1 HMCN1	6.66e-04	182	42	3	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CACHD1 HMCN1 LPA	6.76e-04	183	42	3	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
Drug	Harvard cement	AHR BTK	3.32e-06	2	42	2	CID000158414
Disease	parental longevity	MST1R LAMB2 POM121C ATXN2 HLA-DQB2 LPA MARK4	5.74e-06	494	42	7	EFO_0007796
Disease	neutrophil percentage of leukocytes	GATA3 VSTM4 ATXN2 HLA-DQB2 EMSY MYB MARK4	2.24e-05	610	42	7	EFO_0007990
Disease	bilirubin measurement	AHR CACHD1 SLC22A16 ATXN2 HLA-DQB2 NGEF	3.63e-05	442	42	6	EFO_0004570
Disease	latent autoimmune diabetes in adults, type 2 diabetes mellitus	ATXN2 HLA-DQB2	7.08e-05	9	42	2	EFO_0009706, MONDO_0005148
Disease	eosinophil percentage of leukocytes	GATA3 AHR ATXN2 HLA-DQB2 EMSY MYB MARK4	8.01e-05	746	42	7	EFO_0007991
Disease	heart failure	POM121C ATXN2 HLA-DQB2 LPA	1.39e-04	185	42	4	EFO_0003144
Disease	allergic disease, age at onset	ATXN2 HLA-DQB2 EMSY	1.43e-04	71	42	3	EFO_0004847, MONDO_0005271
Disease	Genetic chronic primary adrenal insufficiency	ATXN2 HLA-DQB2	1.53e-04	13	42	2	Orphanet_101960
Disease	eosinophil count	GATA3 AHR CACHD1 MDN1 ATXN2 HLA-DQB2 EMSY MYB MARK4	2.03e-04	1488	42	9	EFO_0004842
Disease	caffeine measurement	AHR LAMB2	2.05e-04	15	42	2	EFO_0021177
Disease	Antihistamine use measurement	HLA-DQB2 EMSY	2.65e-04	17	42	2	EFO_0009943
Disease	albuminuria	AHR GRM7 LPA	3.28e-04	94	42	3	EFO_0004285
Disease	lymphocyte percentage of leukocytes	GATA3 VSTM4 ATXN2 HLA-DQB2 MYB MARK4	3.37e-04	665	42	6	EFO_0007993
Disease	Inhalant adrenergic use measurement	GATA3 HLA-DQB2 EMSY	3.49e-04	96	42	3	EFO_0009941
Disease	basophil count, eosinophil count	ATXN2 EMSY MYB MARK4	3.81e-04	241	42	4	EFO_0004842, EFO_0005090
Disease	type 1 diabetes mellitus	GATA3 ATXN2 HLA-DQB2 EMSY	3.87e-04	242	42	4	MONDO_0005147
Disease	Autoimmune Hepatitis	ATXN2 HLA-DQB2	4.08e-04	21	42	2	EFO_0005676
Disease	monocyte count	AHR VSTM4 MLLT10 ATXN2 HLA-DQB2 LPA MYB MARK4	4.76e-04	1320	42	8	EFO_0005091
Disease	platelet reactivity measurement, response to clopidogrel	PLEKHA5 GRM7	4.91e-04	23	42	2	EFO_0004985, GO_1903493
Disease	adult onset asthma	GATA3 HLA-DQB2 EMSY	6.39e-04	118	42	3	EFO_1002011
Disease	cutaneous melanoma	AHR ATP11A HLA-DQB2	6.87e-04	121	42	3	EFO_0000389
Disease	asthma, Eczema, allergic rhinitis	ATXN2 HLA-DQB2 EMSY	6.87e-04	121	42	3	EFO_0005854, HP_0000964, MONDO_0004979
Disease	longevity, healthspan, parental longevity	ATXN2 LPA	7.84e-04	29	42	2	EFO_0004300, EFO_0007796, EFO_0009762
Disease	polyunsaturated fatty acid measurement	ATXN2 HLA-DQB2 LPA	8.65e-04	131	42	3	EFO_0010733
Disease	allergic rhinitis	ATXN2 HLA-DQB2 EMSY	9.04e-04	133	42	3	EFO_0005854
Disease	seasonal allergic rhinitis	HLA-DQB2 EMSY	9.55e-04	32	42	2	EFO_0003956
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HLA-DQB2 LPA	1.08e-03	34	42	2	EFO_0008317, EFO_0008596, EFO_0020944
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ATXN2 HLA-DQB2 LPA	1.14e-03	144	42	3	EFO_0004611, EFO_0020943
Disease	Mitral valve prolapse	AREL1 ATXN2	1.21e-03	36	42	2	HP_0001634
Disease	kynurenine measurement	AHR ATXN2	1.42e-03	39	42	2	EFO_0008529

Protein segments in the cluster

Peptide	Gene	Start	Entry
MYQCQPEPQHTHVGQ	AHR	771	P35869
SQVYDVPTQHRGPVV	CASS4	171	Q9NQ75
DPQGVIRHYVVCSTP	BTK	326	Q06187
CEIYPQTIQHNPNGR	COPB2	351	P35606
NRNPSCEVHQEPVTY	CACHD1	991	Q5VU97
QRYTCHVQHEGLPQP	HLA-F	276	P30511
YQHPNVPEARQCQPV	MDN1	3716	Q9NU22
HQQPTPVYTQPVCFA	ATXN2	951	Q99700
PVYCVNVVGTQNAHN	DYNC1I1	391	O14576
THPVYCVNVVGTQNA	DYNC1I2	381	Q13409
PQRGDIYTCQVEHPS	HLA-DQB2	196	P05538
VPCAYHSPQQDNVVS	OR2Z1	261	Q8NG97
PACQNVSAHVPNTYT	NFX1	406	Q12986
NGPQPYCIVSHLQDE	LAMB2	71	P55268
GQQVLPTQNHTCSYP	MYB	311	P10242
QITNVQVPHTGRYTC	HMCN1	2536	Q96RW7
IHQTQYSCPGVLPTV	POM121C	211	A8CG34
TVQRYPPTHHGSQVC	GATA3	71	P23771
QEEQGQYTHVTCGQP	KCNA6	471	P17658
QYTHVTCGQPAPDLR	KCNA6	476	P17658
YHDACPATQQPSVIQ	GHR	436	P10912
CGQPHTLQIVPRDEY	AREL1	181	O15033
APTEQRPGVQECYHG	LPA	131	P08519
PTEQRPGVQECYHGN	LPA	246	P08519
QAPTEQRPGVQECYH	LPA	586	P08519
APTEQRPGVQECYHG	LPA	701	P08519
PTEQRPGVQECYHGN	LPA	816	P08519
PTEQTPVVRQCYHGN	LPA	1606	P08519
IASCPEEQPHVGNYR	MARK4	46	Q96L34
QEIPVVQSIPHPCYN	KLK8	96	O60259
QHCPYDQRPNENRTG	GRM7	561	Q14831
PQYAIPCHSSSNVVV	EMSY	1261	Q7Z589
IQVHNDPQCGSSPYT	OTOG	191	Q6ZRI0
VENQCPTSPSYRGQH	HSF5	396	Q4G112
VCRPPGNVSQVVFHN	SLC22A16	51	Q86VW1
AIYNVSQCPGHQATP	HEPH	711	Q9BQS7
QVQCVHPYVAQQPDE	NGEF	616	Q8N5V2
YHQQGQCQVLVQRSP	TCAP	51	O15273
VHQACYGIVQVPTGP	MLLT10	51	P55197
YVPHVICNGQVLPES	ATP11A	436	P98196
SYQPCFQIHERPQHG	ZNF441	151	Q8N8Z8
ISCRPETHTPNNYGN	ZNF578	196	Q96N58
PGQQTSVIGRCYVQP	PES1	381	O00541
QQGIHRRTPYSTCPE	TMEM221	211	A6NGB7
TLQPSDQGHYVCRVQ	VSTM4	116	Q8IW00
HPVTGQPSQDNCIFV	PLEKHA5	86	Q9HAU0
GSACPAQTVHYRPIN	PLEKHA5	356	Q9HAU0
QVFQVPIQGPGCRHF	MST1R	516	Q04912
QPQRIHSGEKPYACN	ZNF527	291	Q8NB42